14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.52 $2.35 Wednesday, 24th Apr 2024 CYCC stock ended at $2.30. This is 28.49% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 27.02% from a day low at $1.85 to a day high of $2.35.
90 days $1.52 $3.08
52 weeks $1.52 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Feb 12, 2024 $2.30 $2.50 $2.26 $2.46 55 611
Feb 09, 2024 $2.35 $2.35 $2.25 $2.28 32 275
Feb 08, 2024 $2.36 $2.38 $2.23 $2.32 45 618
Feb 07, 2024 $2.51 $2.51 $2.32 $2.33 28 035
Feb 06, 2024 $2.62 $2.74 $2.43 $2.51 188 739
Feb 05, 2024 $2.29 $2.58 $2.20 $2.58 154 719
Feb 02, 2024 $2.19 $2.27 $2.16 $2.23 22 585
Feb 01, 2024 $2.28 $2.28 $2.13 $2.20 34 753
Jan 31, 2024 $2.29 $2.29 $2.17 $2.24 23 889
Jan 30, 2024 $2.14 $2.26 $2.03 $2.22 180 533
Jan 29, 2024 $2.12 $2.35 $2.11 $2.28 234 741
Jan 26, 2024 $2.10 $2.12 $2.04 $2.12 22 839
Jan 25, 2024 $2.14 $2.14 $2.00 $2.08 31 036
Jan 24, 2024 $2.16 $2.16 $2.01 $2.06 20 809
Jan 23, 2024 $2.16 $2.22 $2.07 $2.16 30 896
Jan 22, 2024 $2.11 $2.20 $2.11 $2.20 23 384
Jan 19, 2024 $2.07 $2.24 $2.00 $2.11 40 828
Jan 18, 2024 $2.05 $2.10 $2.00 $2.07 58 819
Jan 17, 2024 $2.30 $2.30 $2.01 $2.09 90 284
Jan 16, 2024 $2.35 $2.36 $2.21 $2.23 95 197
Jan 12, 2024 $2.84 $2.93 $2.22 $2.36 255 142
Jan 11, 2024 $2.94 $3.10 $2.74 $2.78 180 203
Jan 10, 2024 $3.30 $3.36 $3.02 $3.05 242 228
Jan 09, 2024 $3.01 $3.65 $2.73 $3.33 802 338
Jan 08, 2024 $2.68 $3.22 $2.51 $3.19 4 621 199
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT